These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 38091112)

  • 1. HNRNPA2B1-mediated m6A modification of FOXM1 promotes drug resistance and inhibits ferroptosis in endometrial cancer via regulation of LCN2.
    Jiang J; Zhu J; Qiu P; Ni J; Zhu W; Wang X
    Funct Integr Genomics; 2023 Dec; 24(1):3. PubMed ID: 38091112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The N6-methyladenosine modification enhances ferroptosis resistance through inhibiting SLC7A11 mRNA deadenylation in hepatoblastoma.
    Liu L; He J; Sun G; Huang N; Bian Z; Xu C; Zhang Y; Cui Z; Xu W; Sun F; Zhuang C; Man Q; Gu S
    Clin Transl Med; 2022 May; 12(5):e778. PubMed ID: 35522946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. hnRNPA2B1 promotes the occurrence and progression of hepatocellular carcinoma by downregulating PCK1 mRNA via a m6A RNA methylation manner.
    Hao W; Chen Z; Tang J; Yang R; Gao WQ; Xu H
    J Transl Med; 2023 Nov; 21(1):861. PubMed ID: 38017546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FoxM1 expression is significantly associated with cisplatin-based chemotherapy resistance and poor prognosis in advanced non-small cell lung cancer patients.
    Wang Y; Wen L; Zhao SH; Ai ZH; Guo JZ; Liu WC
    Lung Cancer; 2013 Feb; 79(2):173-9. PubMed ID: 23177020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FTO/m6A mediates miR-138-5p maturation and regulates gefitinib resistance of lung adenocarcinoma cells by miR-138-5p/LCN2 axis.
    Ding D; Shang W; Shi K; Ying J; Wang L; Chen Z; Zhang C
    BMC Cancer; 2024 Oct; 24(1):1270. PubMed ID: 39394098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A patient-derived organoid-based study identified an ASO targeting SNORD14E for endometrial cancer through reducing aberrant FOXM1 Expression and β-catenin nuclear accumulation.
    Chen X; Liu X; Li QH; Lu BF; Xie BM; Ji YM; Zhao Y
    J Exp Clin Cancer Res; 2023 Sep; 42(1):230. PubMed ID: 37667311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WTAP Mediates NUPR1 Regulation of LCN2 Through m
    Tan M; He Y; Yi J; Chen J; Guo Q; Liao N; Peng L
    Biochem Genet; 2024 Apr; 62(2):876-891. PubMed ID: 37477758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circular RNA circ_0005667 promotes cisplatin resistance of endometrial carcinoma cells by regulating IGF2BP1 through miR-145-5p.
    Sun G; Tian J; Xiao Y; Zeng Y
    Anticancer Drugs; 2023 Aug; 34(7):816-826. PubMed ID: 36728962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KIAA1429 increases FOXM1 expression through YTHDF1-mediated m6A modification to promote aerobic glycolysis and tumorigenesis in multiple myeloma.
    Wu Y; Luo Y; Yao X; Shi X; Xu Z; Re J; Shi M; Li M; Liu J; He Y; Du X
    Cell Biol Toxicol; 2024 Jul; 40(1):58. PubMed ID: 39060874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The novel circCLK3/miR-320a/FoxM1 axis promotes cervical cancer progression.
    Hong H; Zhu H; Zhao S; Wang K; Zhang N; Tian Y; Li Y; Wang Y; Lv X; Wei T; Liu Y; Fan S; Liu Y; Li Y; Cai A; Jin S; Qin Q; Li H
    Cell Death Dis; 2019 Dec; 10(12):950. PubMed ID: 31831728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of M6A Reader HNRNPA2B1 Associated with Poor Prognosis and Tumor Progression in Lung Adenocarcinoma.
    Wang W; Li S
    Recent Pat Anticancer Drug Discov; 2024; 19(5):652-665. PubMed ID: 37877146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. METTL3 in cancer-associated fibroblasts-derived exosomes promotes the proliferation and metastasis and suppresses ferroptosis in colorectal cancer by eliciting ACSL3 m6A modification.
    Ren H; Wang M; Ma X; An L; Guo Y; Ma H
    Biol Direct; 2024 Aug; 19(1):68. PubMed ID: 39160584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells.
    Hamurcu Z; Ashour A; Kahraman N; Ozpolat B
    Oncotarget; 2016 Mar; 7(13):16619-35. PubMed ID: 26918606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NAT10 promotes the tumorigenesis and progression of laryngeal squamous cell carcinoma through ac4C modification of FOXM1 mRNA.
    Li Z; Li D; Yang T; Yao C
    Cancer Biol Ther; 2023 Dec; 24(1):2274143. PubMed ID: 37948132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FOXM1 Participates in Scleral Remodeling in Myopia by Upregulating APOA1 Expression Through METTL3/YTHDF2.
    Xue M; Li B; Lu Y; Zhang L; Yang B; Shi L
    Invest Ophthalmol Vis Sci; 2024 Jan; 65(1):19. PubMed ID: 38190128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HNRNPA2B1-mediated m
    Li K; Gong Q; Xiang XD; Guo G; Liu J; Zhao L; Li J; Chen N; Li H; Zhang LJ; Zhou CY; Wang ZY; Zhuang L
    J Transl Med; 2023 Jun; 21(1):382. PubMed ID: 37308993
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Wang X; Hu Y; Li X; Zhu C; Chen F
    J Thorac Dis; 2023 Mar; 15(3):1247-1257. PubMed ID: 37065597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. YTHDC1-dependent m6A modification modulated FOXM1 promotes glycolysis and tumor progression through CENPA in triple-negative breast cancer.
    Shen X; Zhong J; Yu P; Liu F; Peng H; Chen N
    Cancer Sci; 2024 Jun; 115(6):1881-1895. PubMed ID: 38566554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HNRNPA2B1-mediated m6A modification of TLR4 mRNA promotes progression of multiple myeloma.
    Jia C; Guo Y; Chen Y; Wang X; Xu Q; Zhang Y; Quan L
    J Transl Med; 2022 Nov; 20(1):537. PubMed ID: 36401285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Forkhead Box M1 Regulates the Proliferation,Invasion,and Drug Resistance of Gastric Cancer Cells
    Ge N; Jiang YY; Pan ZP; Wan J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Oct; 45(5):713-720. PubMed ID: 37927011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.